Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-146P (RNA, U1 small nuclear 146, pseudogene) is a non-coding RNA gene classified as a pseudogene, belonging to the family of U1 small nuclear RNAs which are key components of the spliceosome and essential for pre-mRNA splicing[1][2][8]. Unlike the canonical U1 snRNA genes (such as RNU1-1), RNU1-146P lacks coding potential due to sequence alterations, insertions/delletions or disrupted crucial elements, and is not known to produce functional RNA or protein products[2][8]. While most U1 pseudogenes, including RNU1-146P, have historically been considered nonfunctional, emerging research suggests that some U1 snRNA pseudogenes may be transcribed and could have regulatory roles at the RNA level, though the biological significance of RNU1-146P specifically remains unclear[2]. There is no evidence that RNU1-146P acts as a therapeutic target, is involved in disease mechanisms, or interacts with drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 146, pseudogene (RNU1-146P).